Cardinal Health Inc $ 51.54 0.33 (0.64%)
On watch
Volume:
3,653,191
Avg Vol (1m):
2,874,900
Market Cap $:
15.07 Bil
Enterprise Value $:
20.57 Bil
P/E (TTM):
11.43
P/B:
2.44
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| Peter Lynch Value | ||
| DCF (FCF Based) | ||
| DCF (Earnings Based) | ||
|
Price: $51.54 | ||
Manual of Stocks™ Web
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.32 | ||
| Equity-to-Asset | 0.15 | ||
| Debt-to-Equity | 1.27 | ||
| Debt-to-EBITDA | 2.94 | ||
| Interest Coverage | 5.88 | ||
| Piotroski F-Score | 7 | ||
| Altman Z-Score | 4.21 | ||
| Beneish M-Score | -2.53 | ||
| WACC vs ROIC | |||
Profitability | 8/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 1.19 | ||
| Net Margin % | 0.94 | ||
| ROE % | 22.29 | ||
| ROA % | 3.37 | ||
| ROC (Joel Greenblatt) % | 63.03 | ||
| 3-Year Revenue Growth Rate | 9.5 | ||
| 3-Year EBITDA Growth Rate | -0.9 | ||
| 3-Year EPS without NRI Growth Rate | 1.6 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 11.43 | ||
| Forward PE Ratio | 10.27 | ||
| PE Ratio without NRI | 11.43 | ||
| Price-to-Owner-Earnings | 5.45 | ||
| PB Ratio | 2.44 | ||
| PS Ratio | 0.11 | ||
| Price-to-Free-Cash-Flow | 6.45 | ||
| Price-to-Operating-Cash-Flow | 5.68 | ||
| EV-to-EBIT | 11.88 | ||
| EV-to-EBITDA | 7.52 | ||
| EV-to-Revenue | 0.14 | ||
| PEG Ratio | 2.07 | ||
| Shiller PE Ratio | 16.29 | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.54 | ||
| Days Inventory | 33.3 | ||
| Days Sales Outstanding | 21.19 | ||
| Days Payable | 56.67 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 3.71 | ||
| Dividend Payout Ratio | 0.42 | ||
| 3-Year Dividend Growth Rate | 5.9 | ||
| Forward Dividend Yield % | 3.76 | ||
| 5-Year Yield-on-Cost % | 5.76 | ||
| 3-Year Average Share Buyback Ratio | 3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 0.46 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 1.07 | ||
| Price-to-Median-PS-Value | 0.71 | ||
| Price-to-Peter-Lynch-Fair-Value | 2.09 | ||
| Earnings Yield (Greenblatt) % | 8.44 | ||
| Forward Rate of Return (Yacktman) % | 18.16 |